Bradley Justus Named a Rising Star by Law360
July 15, 2024
Axinn partner Bradley Justus has been named a Rising Star by Law360. Law360's list of Rising Stars recognizes top attorneys under 40 for their career accomplishments in their respective disciplines.
Read the "Rising Star" profile for Bradley Justus here.
Bradley Justus's practice focuses on antitrust law, including antitrust litigation, mergers, government investigations, and counseling. Bradley has represented clients in several of the most high-profile and complex antitrust litigations and deal reviews in recent memory. In addition to appearing in courts throughout the country, before the Department of Justice, and before the Federal Trade Commission, Bradley has represented major clients facing merger reviews by European, Brazilian, Chinese, Korean, Canadian, Mexican, and Japanese competition regulators.
About Axinn
Axinn combines the skills, experience, and dedication of the world’s largest firms with the focus, responsiveness, efficiency, and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property, and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on more than half a trillion dollars in transactions and, in the last 10 years alone, have handled more than 500 litigations.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Forecasting Health Care Antitrust Under a Second Trump Administration
Podcast
Antitrust
GCR 100 2025 Ranks Axinn Antitrust Group in Top Categories
Awards & Recognitions
Antitrust
What Trump’s FTC Picks Mean for Bio-Pharma Dealmaking and PBMs
Media Mentions
Antitrust
Capitol Forum Health Care Competition Conference 2024
Speaking Engagement
Antitrust
Ethical Considerations for Cybersecurity, IP Transactions and Avoiding USPTO Sanctions (EIP241212)
Speaking Engagement
Intellectual Property
Albertsons Ends Merger Deal, Accuses Kroger of ‘Self-Serving Conduct’
Media Mentions
Antitrust